Global Inflammatory Bowel Disease (IBD) Therapeutics Market, Share, Trends & Forecast to 2025The global IBD therapeutics market is estimated to grow significantly at a CAGR of around 5.0% during the forecast period. The rise in the number of IBD such as Crohn's disease and ulcerative colitis is augmenting the growth of the global IBD therapeutics market. The increasing prevalence of IBD results in the need for research for the treatment of IBD and innovations in healthcare systems to manage this complex and costly disease. According to the CDC in the US, the incidence rate for Crohn's disease was 3.1 to 14.6 cases per 100,000 people per year in 2015. The incidence rate of ulcerative colitis was 2.2 to 14.3 cases per 100,000 people per year in 2015. Moreover, the prevalence of IBD in Europe is increasing, according to the European Federation of Crohn's & Ulcerative Colitis Associations (EFCCA), there were 3.4 million cases of IBD in 2016. According to the WHO, the highest rates of IBD are found in, developed countries including the US and UK.
Get Free Sample Copy @ https://www.omrglobal.com/request-sample/ibd-inflammatory-bowel-disease-therapeutics-market
The global IBD therapeutics market is segmented on the basis of disease type and treatment type. The disease type segment includes ulcerative colitis and Crohn's disease. Crohn's disease segment is estimated to dominate the market. The growth of the segment is attributed to the comparatively higher incidence of Crohn's disease than ulcerative colitis. For Crohn's and ulcerative colitis, the development of minimally invasive methods has been evolved with more caution as compared to other colorectal diseases. This is primarily due to disease-related characteristics that are concerned with IBD. The treatment type segment is further segmented into anti-inflammatory drugs and surgery.
A Full Report of Global Inflammatory Bowel Disease (IBD) Therapeutics Market is Available at:https://www.omrglobal.com/industry-reports/ibd-inflammatory-bowel-disease-therapeutics-market
The companies which are contributing to the growth of the global IBD therapeutics market include Abbott Laboratories, AbbVie Inc., Allergan, PLC Celgene Corp., Eli Lilly and Co., Johnson & Johnson Services Inc., Pfizer Inc., and others.
Global IBD Therapeutics Market by Disease Type
Global IBD Therapeutics Market by Treatment Type
Anti- Inflammatory Drug Administration
Rest of Europe
Rest of Asia-Pacific
Rest of the World
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/ibd-inflammatory-bowel-disease-therapeutics-market
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Contact no: +1 646-755-7667, +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Inflammatory Bowel Disease (IBD) Therapeutics Market, Share, Trends & Forecast to 2025 here
News-ID: 2025447 • Views: 517
More Releases from Orion Market Research
Textile Manufacturing Market Comprehensive Insight by Growth Rate, Industry Stat …
The global textile manufacturing market is anticipated to grow at a considerable CAGR of 4.5% during the forecast period (2023-2030). The key driving factor for the market is the versatility of textiles and their several different uses. It is used in the automobile industry, the fashion and apparel industry, the construction industry, and in many other household applications such as bedsheets, towels, carpets, and others. In automobiles, it is used
Service Robotics Market Outlook 2029: Presents Market Insights & Depth Analysis
Service robotics market is anticipated to grow at a CAGR of more than 15% during the forecast period. Service robotics plays a vital role in automation. Service robotics is currently is divided into two parts such as personal/domestic service robots and professional service robots that are used for performing daily tasks, non-commercial use, and others. The service robotics is designed to perform the set of tasks with accuracy and speed.
Smart Manufacturing Market is Anticipated to Increase at a Stable CAGR over the …
The global smart manufacturing market is growing at a significant CAGR of around 12.8% during the forecast period. The market is driven by the rising acceptance of automation in the manufacturing processes, backed by the increasing complexities in supply chain in the industries. In addition, increasing adoption of AI, IoT, industry 4.0, is offering growth opportunity to the smart manufacturing market. The market players are investing a huge amount in
Syringe Trays Market Analysis, Size, Current Scenario and Future Prospects
Syringe Trays Market is anticipated to grow at a significant CAGR during the forecast period. A syringe tray is used for depositing and transporting medical syringes. In one embodiment, a raised portion in the shape of a ridge extends upwardly from the plane of the tray base and includes a wall with holes through which the caps can be positioned in a predetermined manner. Additionally, the tray base can also
More Releases for IBD
Canada Inflammatory Bowel Disease (IBD) Market Size & Growth Analysis Report, 20 …
The Canada IBD market is estimated to grow significantly at a CAGR of around 5.2% during the forecast period. Rising prevalence and incidence of IBD across the country is the major driving factor for the market. Canada has among the highest reported prevalence and incidence rates of IBD across the globe. As per CCC, in 2018, nearly 270,000 Canadians were living with IBD, of which 135,000 individuals with Crohn’s disease,
Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031
Visiongain has published a new report on Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031: Forecasts by Drug Class (Biologics, Aminosalicylates, Corticosteroids, Antibiotics, Immunomodulators, Others), by Indication (Crohn’s Disease, Ulcerative Colitis), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) AND Regional and Leading National Market Analysis PLUS Analysis of Leading IBD Drug Companies AND COVID-19 Recovery Scenarios. Global Inflammatory Bowel Disease (IBD) drugs market was valued at US$ US$xx
US Inflammatory Bowel Disease (IBD) Therapeutics Market Research and Forecast 20 …
The US IBD therapeutics market is estimated to grow significantly at a CAGR of around 4.7% during the forecast period. The factors such as the significant prevalence of IBD such as Crohn’s disease and ulcerative colitis across the country contributing to the market growth. As per the Centers for Disease Control and Prevention (CDC), the prevalence of Crohn’s disease and ulcerative colitis in the US was 201 and 238 per
France Inflammatory Bowel Disease (IBD) Therapeutics Market Size, Growth and For …
France IBD therapeutics market is estimated to grow significantly at a CAGR of around 4.6% during the forecast period. The growing IBD patient population is one of the major driving forces for the growth of the market in the country. According to the National Institutes of, Health, the total number of cases associated with Crohn's disease in France were registered to be around 72,522 in 2017. This signifies the opportunity
Canada Inflammatory Bowel Disease (IBD) Market Share, Size & Forecast to 2025
The Canada IBD market is estimated to grow significantly at a CAGR of around 5.2% during the forecast period. Rising prevalence and incidence of IBD across the country is the major driving factor for the market. Canada has among the highest reported prevalence and incidence rates of IBD across the globe. As per CCC, in 2018, nearly 270,000 Canadians were living with IBD, of which 135,000 individuals with Crohn's disease,
Indian IBD Therapeutics Market Growth, Opportunity, Size, Share and Forecast 201 …
Indian IBD therapeutics market is estimated to grow significantly at a CAGR of around 6.2% during the forecast period. The Indian pharmaceutical industry has been consistently growing with the public and private investments, making India as a potential market for the treatment of prevailing diseases such as IBD. Additionally, healthcare expenditure is playing a critical role in fueling the IBD therapeutics market in India. Request a Free Sample of our